vioxx

    By Melly Alazraki

    | 6:20PM 11/24/2009
    It seems that for Pfizer (PFE), the saga of Prempro is just beginning. Barely a month after the world's largest pharmaceutical company lost a case related to Wyeth's Prempro hormone replacement therapy drug and was ordered to pay punitive damages on top of earlier compensatory damages, it lost the...

    By Melly Alazraki

    | 1:30PM 6/05/2009
    Major drug companies are declining more than the general market today, but none like Merck & Co. (MRK). Merck's shares dropped 2.5 percent on news it won't seek approval this year for its heart-failure drug rolofylline after preliminary results of a Phase III study failed to meet...